Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First in Human Study to Evaluate Safety of Cellavita HD Investigational Product After Intravenous Application in Participants With Huntington's Disease

NCT02728115 is registered in ClinicalTrials.gov with Azidus Brasil as lead sponsor.

NCT NCT02728115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02728115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First in Human Study to Evaluate Safety of Cellavita HD Investigational Product After Intravenous Application in Participants With Huntington's Disease
Lead sponsor
Azidus Brasil
Phase
Phase 1
Overall status
Unknown status
Start date
October 16, 2017
Completion date
December 31, 2023
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

huntington disease